Due to a measles case in the community, please call before coming to Seattle Children’s if you or your child has potential measles symptoms.

Current Research Studies

SC-N133; ON-TRK: PrOspective Non-interventional study in patients with locally advanced or metastatic TRK fusion cancer treated with larotrectinib

SC-N133

Condition: Adrenal Tumors
Phase: N/A
Clinicaltrials.gov ID: NCT04142437

What is the goal of the study?

PrOspective Non-interventional study in patients with locally advanced or metastatic TRK fusion cancer treated with larotrectinib

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

PI (Study Doctor): Douglas Hawkins
Study Team Member: Palee Abeyta, Palee.Abeyta@seattlechildrens.org

Seattle Children’s complies with applicable federal and other civil rights laws and does not discriminate, exclude people or treat them differently based on race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry), age, disability, or any other status protected by applicable federal, state or local law. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.